BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16596771)

  • 1. Cannabinoid receptor signaling.
    Howlett AC
    Handb Exp Pharmacol; 2005; (168):53-79. PubMed ID: 16596771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction of the CB1 cannabinoid receptor.
    Turu G; Hunyady L
    J Mol Endocrinol; 2010 Feb; 44(2):75-85. PubMed ID: 19620237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid signalling.
    Demuth DG; Molleman A
    Life Sci; 2006 Jan; 78(6):549-63. PubMed ID: 16109430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The second intracellular loop of the human cannabinoid CB2 receptor governs G protein coupling in coordination with the carboxyl terminal domain.
    Zheng C; Chen L; Chen X; He X; Yang J; Shi Y; Zhou N
    PLoS One; 2013; 8(5):e63262. PubMed ID: 23667597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
    Sterin-Borda L; Del Zar CF; Borda E
    Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of G protein signals by extracellular signal-regulated protein kinases in SK-N-MC neuroepithelioma cells.
    Chan AS; Yeung WW; Wong YH
    J Neurochem; 2005 Sep; 94(5):1457-70. PubMed ID: 15992362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line.
    Begg M; Baydoun A; Parsons ME; Molleman A
    J Physiol; 2001 Feb; 531(Pt 1):95-104. PubMed ID: 11179394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists.
    Dhopeshwarkar A; Murataeva N; Makriyannis A; Straiker A; Mackie K
    J Pharmacol Exp Ther; 2017 Feb; 360(2):300-311. PubMed ID: 27927913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
    Small-Howard AL; Shimoda LM; Adra CN; Turner H
    Biochem J; 2005 Jun; 388(Pt 2):465-73. PubMed ID: 15669919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
    Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
    Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
    J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages.
    Han KH; Lim S; Ryu J; Lee CW; Kim Y; Kang JH; Kang SS; Ahn YK; Park CS; Kim JJ
    Cardiovasc Res; 2009 Dec; 84(3):378-86. PubMed ID: 19596672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis.
    Rios C; Gomes I; Devi LA
    Br J Pharmacol; 2006 Jun; 148(4):387-95. PubMed ID: 16682964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
    Mo FM; Offertáler L; Kunos G
    Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
    Robinson AJ; Dickenson JM
    Eur J Pharmacol; 2001 Feb; 413(2-3):151-61. PubMed ID: 11226388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of cannabinoid receptors.
    Abood ME
    Handb Exp Pharmacol; 2005; (168):81-115. PubMed ID: 16596772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.